Jesper Brandgaard/LinkedIn
Dec 7, 2025, 05:45
Jesper Brandgaard: Novo Nordisk Haemophilia Foundation is Evolving into the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation
Jesper Brandgaard, Chairman at LEO Pharma, posted on LinkedIn:
“As the former President of the Council, I am absolutely delighted to share that the Novo Nordisk Haemophilia Foundation is evolving into the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation. It’s truly inspiring to witness the mission grow to support even more lives. A huge thank you to the Novo Nordisk Foundation for joining as an accelerating partner on this ambitious journey to quadruple the annual beneficiaries by 2030.
Congratulations to the entire NNHF Council and Team – here’s to an exciting new era ahead!”
Get the latest with Hemostasis Today.
-
Oct 21, 2026, 17:55Gayatri Kotwal։ New Review on Anemia, Pain, and Nutritional Deficiencies in Cancer Patients
-
Oct 21, 2026, 17:40Tetsuzan Ron: Iron Deficiency Without Anemia Clinical Impact and Management
-
Oct 21, 2026, 17:29Amir Hossien Esfandiari։ The Association Between Viral Infections and Aplastic Anemia
-
Oct 21, 2026, 17:16Melissa Hollo: A Meaningful Step Forward for Women’s Health
-
Oct 21, 2026, 17:09Chipili Ng’onga: Have You Ever Seen a Result That Just Didn’t Make Sense?
-
Oct 21, 2026, 16:57Fabrice Cognasse: Celebrating the Next Generation of Platelet Research and Transfusion Medicine
-
Oct 21, 2026, 16:47Christabel Odeta: Treating Pediatric Cancer in Children With Sickle Cell Disease
-
Oct 21, 2026, 16:36Sharlene Haywood: Bringing Multidisciplinary Learning Into Nursing Practice
-
Oct 21, 2026, 16:19Vanessa Carvalho: New Research on Platelet-Derived Extracellular Vesicles in Preeclampsia